• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2021 Apr 2;27(5).
doi: 10.3201/eid2705.204912. Online ahead of print.
Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil

Natalia Fintelman-Rodrigues, Aline P D da Silva, Monique Cristina Dos Santos, Felipe B Saraiva, Marcelo A Ferreira, Jo?o Gesto, Danielle A S Rodrigues, Andr? M Vale, Isaclaudia G de Azevedo, Vin?cius C Soares, Hui Jiang, Hongdong Tan, Diogo A Tschoeke, Carolina Q Sacramento, Fernando A Bozza, Carlos M Morel, Patr?cia T Bozza, Thiago Moreno L Souza

Abstract

The dynamics underlying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection remain poorly understood. We identified a small cluster of patients in Brazil who experienced 2 episodes of coronavirus disease (COVID-19) in March and late May 2020. In the first episode, patients manifested an enhanced innate response compared with healthy persons, but neutralizing humoral immunity was not fully achieved. The second episode was associated with different SARS-CoV-2 strains, higher viral loads, and clinical symptoms. Our finding that persons with mild COVID-19 may have controlled SARS-CoV-2 replication without developing detectable humoral immunity suggests that reinfection is more frequent than supposed, but this hypothesis is not well documented.

Keywords: Brazil; COVID-19; SARS-CoV-2; coronavirus disease; humoral response; next-generation sequencing; reinfection; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom